BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38184148)

  • 1. Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients.
    de la Iglesia-San Sebastián I; Carbonell D; Bastos-Oreiro M; Pérez-Corral A; Bailén R; Chicano M; Muñiz P; Monsalvo S; Escudero-Fernández A; Oarbeascoa G; Fernández-Caldas P; Gómez-Centurión I; Pion M; Gayoso J; Anguita J; Kwon M; Díez-Martín JL; Buño I; Martínez-Laperche C
    Transplant Cell Ther; 2024 Mar; 30(3):306.e1-306.e12. PubMed ID: 38184148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital polymerase chain reaction strategies for accurate and precise detection of vector copy number in chimeric antigen receptor T-cell products.
    Murphy LA; Marians RC; Miller K; Brenton MD; Mallo RLV; Kohler ME; Fry TJ; Winters AC
    Cytotherapy; 2023 Jan; 25(1):94-102. PubMed ID: 36253252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients.
    Haderbache R; Warda W; Hervouet E; da Rocha MN; Trad R; Allain V; Nicod C; Thieblemeont C; Boissel N; Varlet P; Agha IY; Bouquet L; Guiot M; Venet F; Sujobert P; Roussel X; Rouzaire PO; Caillot D; Casasnovas O; Bories JC; Bachy E; Caillat-Zucman S; Deschamps M; Ferrand C
    J Transl Med; 2021 Jun; 19(1):265. PubMed ID: 34154602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioanalytical Methods for Characterization of CAR-T Cellular Kinetics: Comparison of PCR Assays and Matrices.
    Masilamani M; Jawa V; Dai Y; Das R; Park A; Lamba M; Wu F; Zheng X; Lu E; Gleason C; Mack T; Mora J; Surapaneni S
    Clin Pharmacol Ther; 2023 Sep; 114(3):664-672. PubMed ID: 37422675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of FACS and PCR for Detection of BCMA-CAR-T Cells.
    Reichman A; Kunz A; Joedicke JJ; Höpken UE; Keib A; Neuber B; Sedloev D; Wang L; Jiang G; Hückelhoven-Krauss A; Eberhardt F; Müller-Tidow C; Wermke M; Rehm A; Schmitt M; Schmitt A
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenge of standardizing CAR-T cell monitoring: A comparison of two flow-cytometry methods and correlation with qPCR technique.
    Valdivieso-Shephard JL; Matas-Pérez E; García-Bujalance S; Mirones-Aguilar I; González-Martínez B; Pérez-Martínez A; López-Granados E; Martínez-Feito A; Sánchez-Zapardiel E
    Cytometry A; 2024 May; 105(5):368-375. PubMed ID: 38327134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patients.
    Schubert ML; Berger C; Kunz A; Schmitt A; Badbaran A; Neuber B; Zeschke S; Wang L; Riecken K; Hückelhoven-Krauss A; Müller I; Müller-Tidow C; Dreger P; Kröger N; Ayuk FA; Schmitt M; Fehse B
    Int J Oncol; 2022 May; 60(5):. PubMed ID: 35294040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring anti-CD19 chimeric antigen receptor T cell population by flow cytometry and its consistency with digital droplet polymerase chain reaction.
    Cheng J; Mao X; Chen C; Long X; Chen L; Zhou J; Zhu L
    Cytometry A; 2023 Jan; 103(1):16-26. PubMed ID: 35875964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric Antigen Receptor T Cell Therapy for Pediatric B-ALL: Narrowing the Gap Between Early and Long-Term Outcomes.
    Schultz L
    Front Immunol; 2020; 11():1985. PubMed ID: 32849662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and toxicity for CD22/CD19 chimeric antigen receptor T-cell therapy in patients with relapsed/refractory aggressive B-cell lymphoma involving the gastrointestinal tract.
    Zeng C; Cheng J; Li T; Huang J; Li C; Jiang L; Wang J; Chen L; Mao X; Zhu L; Lou Y; Zhou J; Zhou X
    Cytotherapy; 2020 Mar; 22(3):166-171. PubMed ID: 32063474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma.
    Wittibschlager V; Bacher U; Seipel K; Porret N; Wiedemann G; Haslebacher C; Hoffmann M; Daskalakis M; Akhoundova D; Pabst T
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies.
    García-Calderón CB; Sierro-Martínez B; García-Guerrero E; Sanoja-Flores L; Muñoz-García R; Ruiz-Maldonado V; Jimenez-Leon MR; Delgado-Serrano J; Molinos-Quintana Á; Guijarro-Albaladejo B; Carrasco-Brocal I; Lucena JM; García-Lozano JR; Blázquez-Goñi C; Reguera-Ortega JL; González-Escribano MF; Reinoso-Segura M; Briones J; Pérez-Simón JA; Caballero-Velázquez T
    Front Immunol; 2023; 14():1152498. PubMed ID: 37122702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric Antigen Receptor T-Cell Therapies for Aggressive B-Cell Lymphomas: Current and Future State of the Art.
    Abramson JS; Lunning M; Palomba ML
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():446-453. PubMed ID: 31099671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring CAR-T cell kinetics in clinical trials by multiparametric flow cytometry: Benefits and challenges.
    Sarikonda G; Pahuja A; Kalfoglou C; Burns K; Nguyen K; Ch'en IL; Pollner R; Tangri S; Dakappagari N
    Cytometry B Clin Cytom; 2021 Jan; 100(1):72-78. PubMed ID: 32573972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Real-Time Quantitative PCR Targeting the Viral Vector for the Monitoring of Patients Treated with Axicabtagene Ciloleucel.
    Baras A; Bocket L; Beauvais D; Hallaert C; Varlet P; Yakoub-Agha I; Hober D; Alidjinou EK
    J Mol Diagn; 2021 Apr; 23(4):447-454. PubMed ID: 33385585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and Quantification of Chimeric Antigen Receptor Transgene Copy Number by Droplet Digital PCR versus Real-Time PCR.
    Lou Y; Chen C; Long X; Gu J; Xiao M; Wang D; Zhou X; Li T; Hong Z; Li C; Zhou J; Chen L
    J Mol Diagn; 2020 May; 22(5):699-707. PubMed ID: 32409121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR).
    Galli E; Viscovo M; Fosso F; Pansini I; Di Cesare G; Iacovelli C; Maiolo E; Sorà F; Hohaus S; Sica S; Bellesi S; Chiusolo P
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell Lymphoma.
    Messerli C; Wiedemann G; Porret N; Nagler M; Seipel K; Jeker B; Novak U; Zeerleder S; Bacher U; Pabst T
    Turk J Haematol; 2023 Aug; 40(3):187-196. PubMed ID: 37519105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia.
    Zhang C; He J; Liu L; Wang J; Wang S; Liu L; Ge J; Gao L; Gao L; Kong P; Liu Y; Liu J; Han Y; Zhang Y; Sun Z; Ye X; Yin W; Sersch M; Shen L; Cao WW; Zhang X
    Blood Cancer J; 2022 Jun; 12(6):96. PubMed ID: 35750687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment and CAR-T cell immunotherapy in B-cell lymphoma.
    Cai F; Zhang J; Gao H; Shen H
    Eur J Haematol; 2024 Feb; 112(2):223-235. PubMed ID: 37706523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.